DTX401
401GSDIA01
Phase 2 gene_therapy completed
Quick answer
DTX401 for GSD1 is a Phase 2 program (gene_therapy) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx Pharmaceutical
- Indication
- GSD1
- Phase
- Phase 2
- Modality
- gene_therapy
- Status
- completed